Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice

Carcinogenesis

Volumn 25, Issue 3, 2004, Pages 309-315

  Kleymenova, Elena ^a   Everitt, Jeffrey I ^a,d   Pluta, Linda ^a   Portis, Melisa ^b   Gnarra, James R ^c   Walker, Cheryl Lyn ^b  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; HYPOXIA INDUCIBLE FACTOR 1; STREPTOZOCIN; VON HIPPEL LINDAU PROTEIN;

ANGIOGENESIS; ANGIOSARCOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD VESSEL INJURY; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; GENE FUNCTION; GENE LOCUS; GENE MUTATION; HEART INJURY; HEMANGIOMA; HETEROZYGOSITY; HETEROZYGOTE; KIDNEY CARCINOMA; KIDNEY INJURY; KNOCKOUT MOUSE; LIVER BLOOD VESSEL; LIVER INJURY; MOUSE; NONHUMAN; OVARY DISEASE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TUMOR SUPPRESSOR GENE; UTERUS DISEASE; VASCULAR TUMOR; WILD TYPE;

ANIMALS; CARCINOGENS; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; KIDNEY NEOPLASMS; LIVER; MICE; MICE, KNOCKOUT; MYOCARDIUM; PROTEIN-TYROSINE-PHOSPHATASE; STREPTOZOCIN; UTERUS; VASCULAR NEOPLASMS;

EID: 1542399554     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh017     Document Type: Review

References (57)

1. Thoenes,W., Storkel,S. and Rumpelt,H.J. (1986) Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol. Res. Pract., 181, 125-143.
2. Kovacs,G., Akhtar,M., Beckwith,B.J. et al. (1997) The Heidelberg classification of renal cell tumours. J. Pathol., 183, 131-133.
3. Zbar,B. and Lerman,M. (1998) Inherited carcinomas of the kidney. Adv. Cancer Res., 75, 163-201.
4. Gnarra,J.R., Tory,K., Weng,Y. et al. (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genet., 7, 85-90.
5. Tsuda,H. and Krieg,K. (1992) Neoplastic lesions in the kidney. In Mohr,U., Dungworth,D.L. and Capen,C.C. (eds), Pathobiology of the Aging Rat. ILSI Press, Washington DC, pp. 227-240.
6. National,T.P. (2002) Chemicals associated with site-specific tumor induction in kidney tubular cell. Toxicology data management system database http://ntp-server.niehs.nih.gov/htdocs/sites/psite_cnt.html.
7. Gnarra,J.R., Ward,J.M., Porter,F.D. et al. (1997) Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc. Natl Acad. Sci. USA, 94, 9102-9107.
8. Walker,C., Goldsworthy,T.L., Wolf,D.C. and Everitt,J. (1992) Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene. Science, 255, 1693-1695.
9. Yeung,R.S., Xiao,G.H., Jin,F., Lee,W.C., Testa,J.R. and Knudson,A.G. (1994) Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc. Natl Acad. Sci. USA, 91, 11413-11416.
10. Kobayashi,T., Hirayama,Y., Kobayashi,E., Kubo,Y. and Hino,O. (1995) A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nature Genet., 9, 70-74.
11. Kobayashi,T., Minowa,O., Kuno,J., Mitani,H., Hino,O. and Noda,T. (1999) Renal carcinogenesis, hepatic hemangiomatosis and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer Res., 59, 1206-1211.
12. Onda,H., Lueck,A., Marks,P.W., Warren,H.B. and Kwiatkowski,D.J. (1999) Tsc2 (+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J. Clin. Invest., 104, 687-695.
13. Kobayashi,T., Urakami,S., Hirayama,Y., Yamamoto,T., Nishizawa,M., Takahara,T., Kubo,Y. and Hino,O. (1997) Intragenic Tsc2 somatic mutations as Knudson's second hit in spontaneous and chemically induced renal carcinomas in the Eker rat model. Jpn. J. Cancer Res., 88, 254-261.
14. Walker,C., Ahn,Y.T., Everitt,J. and Yuan,X. (1996) Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus. Mol. Carcinogen., 15, 154-161.
15. Kubo,Y., Mitani,H. and Hino,O. (1994) Allelic loss at the predisposing gene locus in spontaneous and chemically induced renal cell carcinomas in the Eker rat. Cancer Res., 54, 2633-2635.
16. Urakami,S., Tokuzen,R., Tsuda,H., Igawa,M. and Hino,O. (1997) Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell. J. Urol., 158, 275-278.
17. Kikuchi,Y., Kobayashi,E., Nishizawa,M., Hamazaki,S., Okada,S. and Hino,O. (1995) Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas. Jpn. J. Cancer Res., 86, 905-909.
18. Satake,N., Urakami,S., Hirayama,Y., Izumi,K. and Hino,O. (1998) Biallelic mutations of the Tsc2 gene in chemically induced rat renal cell carcinoma. Int. J. Cancer, 77, 895-900.
19. Shiao,Y.H., Diwan,B.A., Perantoni,A.O., Calvert,R.J., Zbar,B., Lerman,M.I. and Rice,J.M. (1997) Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers. Mol. Carcinogen., 19, 230-235.
20. Shiao,Y.H., Rice,J.M., Anderson,L.M., Diwan,B.A. and Hard,G.C. (1998) von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors. J. Natl Cancer Inst., 90, 1720-1723.
21. Friedrich,C. (2001) Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum. Mol. Genet., 7, 763-767.
22. Neumann,H.P. (1987) Basic criteria for clinical diagnosis and genetic counselling in von Hippel-Lindau syndrome. Vasa, 16, 220-226.
23. Kondo,K. and Kaelin,W.G.,Jr (2001) The von Hippel-Lindau tumor suppressor gene. Exp. Cell Res., 264, 117-125.
24. 2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol., 15, 551-578.
25. Maxwell,P.H., Wiesener,M.S., Chang,G.W., Clifford,S.C., Vaux,E.C., Cockman,M.E., Wykoff,C.C., Pugh,C.W., Maher,E.R. and Ratcliffe,P.J. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399, 271-275.
26. Ohh,M., Park,C.W., Ivan,M., Hoffman,M.A., Kim,T.Y., Huang,L.E., Pavletich,N., Chau,V. and Kaelin,W.G. (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nature Cell Biol., 2, 423-427.
27. 2 sensing. Science, 292, 464-468.
28. Tanimoto,K., Makino,Y., Pereira,T. and Poellinger,L. (2000) Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J., 19, 4298-4309.
29. 2-regulated prolyl hydroxylation. Science, 292, 468-472.
30. Wiesener,M.S., Munchenhagen,P.M., Berger,I. et al. (2001) Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res., 61, 5215-5222.
31. Gnarra,J.R., Zhou,S., Merrill,M.J., Wagner,J.R., Krumm,A., Papavassiliou,E., Oldfield,E.H., Klausner,R.D. and Linehan,W.M. (1996) Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl Acad. Sci. USA, 93, 10589-10594.
32. Turner,K.J., Moore,J.W., Jones,A. et al. (2002) Expression of hypoxia-inducible factors in human renal cancer: Relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res., 62, 2957-2961.
33. Krieg,M., Haas,R., Brauch,H., Acker,T., Flamme,I. and Plate,K.H. (2000) Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene, 19, 5435-5443.
34. Iliopoulos,O., Levy,A.P., Jiang,C., Kaelin,W.G.,Jr and Goldberg,M.A. (1996) Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl Acad. Sci. USA, 93, 10595-10599.
35. Ferrara,N. (2002) VEGF and the quest for tumour angiogenesis factors. Nature Rev. Cancer, 2, 795-803.
36. Shibuya,M. (2001) Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct. Funct., 26, 25-35.
37. Hard,G. (1985) Identification of a high-frequency model for renal carcinoma by the induction of renal tumors in the mouse with a single dose of streptozotocin. Cancer Res., 45, 703-708.
38. Gruys,M., Back,T., Subleski,J., Wiltrout,T., Lee,J., Schmidt,L., Watanabe,M., Stanyon,R., Ward,J., Wigginton,J. and Wiltrout,R. (2001) Induction of transplantable mouse renal cell cancers by streptozotocin: In vivo growth, metastases and angiogenic phenotype. Cancer Res., 61, 6255-6263.
39. Horton,L., Fox,C., Corrin,B. and Sonksen,P.H. (1977) Streptozotocin-induced renal tumours in rats. Br. J. Cancer, 36, 692-699.
40. Delahunt,B. and Wakefield,J.S. (1997) Ultrastructure of streptozotocin-induced renal tumours in mice. Virch. Arch., 430, 173-180.
41. Haines,D.C., Chattopadhyay,S. and Ward,J.M. (2001) Pathology of aging B6;129 mice. Toxicol. Pathol., 29, 653-661.
42. Lombard,L.S., Rice,J.M. and Vesselinovitch,S.D. (1974) Renal tumors in mice: Light microscopic observations of epithelial tumors induced by ethylnitrosourea. J. Natl Cancer Inst., 53, 1677-1685.
43. Edwards,R., Colombo,T. and Greaves,P. (2002) 'Have you seen this?' Peliosis hepatis. Toxicol. Pathol., 30, 521-523.
44. Wong,A.K., Alfert,M., Castrillon,D.H., Shen,Q., Holash,J., Yancopoulos,G.D. and Chin,L. (2001) Excessive tumor-elaborated VEGF and its neutralization define a lethal paraneoplastic syndrome. Proc. Natl Acad. Sci. USA, 98, 7481-7486.
45. Booth,C.J. and Sundberg,J.P. (1995) Hemangiomas and hemangiosarcomas in inbred laboratory mice. Lab. Anim. Sci., 45, 497-502.
46. Haase,V., Glickman,J., Socolovsky,M. and Jaenisch,R. (2001) Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc. Natl Acad. Sci. USA, 98, 1583-1588.
47. Ludwig,J. and Hoffman,H.N. (1975) Hemangiosarcoma of the liver. Spectrum of morphologic changes and clinical findings. Mayo Clin. Proc., 50, 255-263.
48. Wright,J.A., Marsden,A.M., Willets,J.M. and Orton,T.C. (1991) Hepatocarcinogenic effect of vinyl carbamate in the C57B1/10J strain mouse. Toxicol. Pathol., 19, 258-265.
49. Bogdanffy,M.S., Makovec,G.T. and Frame,S.R. (1995) Inhalation oncogenicity bioassay in rats and mice with vinyl fluoride. Fund. Appl. Toxicol., 26, 223-238.
50. Hong,H.H., Devereux,T.R., Melnick,R.L., Moomaw,C.R., Boorman,G.A. and Sills,R.C. (2000) Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years. Toxicol. Pathol., 28, 529-534.
51. Ward,J.M., Anver,M., Mahler,J. and Devor-Henneman,D. (2000) Pathology of mice commonly used in genetic engineering (C57B1/6, 129, B6;129 and FVB/N). In Ward,J.M., Mahler,J.F., Maronpot,R.R. and Sundberg,J.P. (eds) Pathology of Genetically Engineered Mice. Iowa State University Press, Ames, Iowa, pp. 161-179.
52. Huff,J.E., Melnick,R.L., Solleveld,H.A., Haseman,J.K., Powers,M. and Miller,R.A. (1985) Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science, 227, 548-589.
53. Liu,M.Y., Poellinger,L. and Walker,C.L. (2003) Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene. Cancer Res., 63, 2675-2680.
54. Brugarolas,J.B., Vazquez,F., Reddy,A., Sellers,W.R. and Kaelin,W.G.,Jr (2003) TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell, 4, 147-158.
55. Everitt,J.I., Goldsworthy,T.L., Wolf,D.C. and Walker,C.L. (1992) Hereditary renal cell carcinoma in the Eker rat: A rodent familial cancer syndrome. J. Urol., 148, 1932-1936.
56. Allen,D., Moyer,C., Basabe,A., Maronpot,R. and Nyska,A. (2003) Riddelliine exposure induces alterations in VEGF expression in rat liver: A possible mechanism for hemangiosarcoma formation. Toxicol. Pathol., 31 (suppl.), 143.
57. Moyer,C., Basabe,A., Allen,D., Maronpot,R. and Nyska,A. (2003) Riddelliine exposure induces activated VEGFR-2 expression in rat liver endothelium: A possible mechanism for hemangiosarcoma formation. Toxicol. Pathol., 31 (suppl.), 143.